AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Topical emollients and/or topical corticosteroids may be adequate to treat mild to moderate non-exfoliative rashes ... with chemotherapy followed by olaparib and IMFINZIis approved for patients ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of ...

Based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death vs. neoadjuvant chemotherapy alone WILMINGTON, Del.

IMFINZI in combination with chemotherapy followed by olaparib and IMFINZI is approved for patients with mismatch repair proficient advanced or recurrent endometrial cancer in EU and Japan.

Eat this meal plan to cure your chronic health condition. Follow this exercise regime to balance your hormones. Is your face puffy? That’s due to cortisol; it can be rectified by completing ...

The majority of the fungal diseases seen in the UK are skin infections like athlete’s foot and ringworm, which trigger itchy rashes, usually in crevices like the buttocks, genitals and armpits.

Rashes can be maddeningly itchy, no matter what the cause. Doctors are likely to prescribe creams, lotions, or antihistamines for relief. They may also suggest cold compresses or other home remedies.